Timothy Sullivan

Timothy Sullivan is the Chief Financial Officer at Apellis Pharmaceuticals. Prior to their current role, Timothy was a Partner at AJU IB INVESTMENT focusing on life sciences venture capital. Timothy also served as a Member of the Board of Directors at Molecular Templates and G1 Therapeutics, Inc. Timothy has a background in investment banking, healthcare banking, and corporate development, with a strong focus on the life sciences industry. Timothy holds an MBA from Columbia Business School and a BA in Biology from Harvard University.